# OnCo record icp-248 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/icp-248/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "icp-248" ;
  schema:name "ICP-248"@en ;
  schema:description "ICP-248 is an experimental small-molecule drug from Beijing InnoCare Pharma Tech in phase 3 trials for mantle cell lymphoma and chronic lymphocytic leukaemia, with its target not yet stated publicly."@en ;
  schema:url <https://onco.cc/drugs/icp-248/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=ICP-248> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "small molecule (structure undisclosed or not yet in PubChem)" ;
  onco:cancers <https://onco.cc/cancers/mantle-cell-lymphoma/>, <https://onco.cc/cancers/cll/> ;
  onco:companies <https://onco.cc/companies/innocare/> ;
  onco:trials <https://onco.cc/trials/apex-03/>, <https://onco.cc/trials/nct07082686/> .